Steven J. Moss

2.3k citations

40 papers · 1.6k indexed · h-index 23

Co-authors: Barrie Wilkinson Christine Martin Peter F. Leadlay Heinz G. Floss Rose Sheridan Tin‐Wein Yu Linquan Bai Matthew A. Gregory
Topics: Microbial Natural Products and Biosynthesis (17 papers)Signaling Pathways in Disease (9 papers)Synthetic Organic Chemistry Methods (8 papers)
Cited by: Pharmacology Biotechnology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Angewandte Chemie International Edition
Partner nations: United Kingdom United States Spain

In The Last Decade

Steven J. Moss

38 papers receiving 1.6k citations

Peers

Countries citing papers authored by Steven J. Moss

Since Specialization

Citations

This map shows the geographic impact of Steven J. Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Moss more than expected).

Fields of papers citing papers by Steven J. Moss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Moss. The network helps show where Steven J. Moss may publish in the future.

Co-authorship network of co-authors of Steven J. Moss

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Moss. A scholar is included among the top collaborators of Steven J. Moss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Moss. Steven J. Moss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Net Zero Transition: Possible Implications for Catalysis 2023 ·ACS Catalysis ·R.M. Bellabarba,Peter Johnston,Steven J. Moss,Carsten Sievers,Bala Subramaniam,Cathy L. Tway,(unknown),Hongda Zhu	22
2	Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency 2016 ·Nature Communications ·Johannes K. Ehinger,Sarah Piel,(unknown),Michael Karlsson,Fredrik Sjövall,Eleonor Åsander Frostner,Saori Morota,Robert W. Taylor,Douglass M. Turnbull,Clive L. Cornell,Steven J. Moss,Carsten Metzsch,Magnus J. Hansson,Hans Fliri,Eskil Elmér	104
3	Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection 2015 ·Chemistry & Biology ·Magnus J. Hansson,Steven J. Moss,Michael Bobardt,Udayan Chatterji,Nigel Coates,Jose A. Garcia-Rivera,Eskil Elmér,(unknown),Pieter Leyssen,Johan Neyts,Mohammad Nur‐e‐Alam,(unknown),Barrie Wilkinson,Philippe Gallay,Matthew A. Gregory	27
4	Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo 2014 ·Proceedings of the National Academy of Sciences ·Eva Maria Novoa,Noelia Camacho,(unknown),Barrie Wilkinson,Steven J. Moss,Patricia Marín‐García,(unknown),José M. Bautista,Adam C. Mirando,Christopher S. Francklyn,(unknown),Míriam Royo,Alfred Cortés,Lluı́s Ribas de Pouplana	61
5	Recombinant strains for the enhanced production of bioengineered rapalogs 2012 ·Metabolic Engineering ·Steven G. Kendrew,Hrvoje Petković,Sabine Gaisser,(unknown),Matthew A. Gregory,Nigel J. Coates,Mohammad Nur‐e‐Alam,(unknown),(unknown),Teresa A. Foster,Leonard A. McDonald,(unknown),Frank E. Koehn,Jerauld S. Skotnicki,Guy T. Carter,Steven J. Moss,Ming‐Qiang Zhang,Christine Martin,Rose Sheridan,Barrie Wilkinson	11
6	Total Synthesis of Chloptosin: A Dimeric Cyclohexapeptide 2011 ·Chemistry - A European Journal ·Alexander J. Oelke,(unknown),(unknown),(unknown),David J. France,Rebecca J. M. Goss,(unknown),(unknown),Steven J. Moss,(unknown),Richard M. Turner,Georg Wuitschik,Steven V. Ley	30
7	An Expeditious Route to Fluorinated Rapamycin Analogues by Utilising Mutasynthesis 2010 ·ChemBioChem ·Rebecca J. M. Goss,(unknown),Abhijeet Deb Roy,(unknown),(unknown),David L. Hughes,Barrie Wilkinson,Steven J. Moss	25
8	Brain-selective mTOR inhibitors as potential therapeutics for glioblastoma multiforme 2006 ·Cancer Research ·Rose Sheridan,Matthew A. Gregory,Hrvoje Petković,Sabine Gaisser,(unknown),Michael J. Ward,(unknown),(unknown),Iain R. Challis,Steven J. Moss,Barrie Wilkinson,Peter J. Houghton,Ming‐Qiang Zhang	1
9	Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain 2006 ·Bioorganic & Medicinal Chemistry Letters ·Barrie Wilkinson,Matthew A. Gregory,Steven J. Moss,Isabelle Carletti,Rose Sheridan,(unknown),Michael J. Ward,Carlos Olano,Cármen Méndez,José A. Salas,Peter F. Leadlay,(unknown),Ming‐Qiang Zhang	37
10	Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analogues 2006 ·Chemical Communications ·Steven J. Moss,Isabelle Carletti,Carlos Olano,Rose Sheridan,Michael J. Ward,(unknown),Mohammad Nur‐e‐Alam,Alfredo F. Braña,(unknown),Peter F. Leadlay,Cármen Méndez,José A. Salas,Barrie Wilkinson	37
11	Generating rapamycin analogues by directed biosynthesis: starter acid substrate specificity of mono-substituted cyclohexane carboxylic acids 2006 ·Organic & Biomolecular Chemistry ·Rebecca J. M. Goss,(unknown),(unknown),Steven J. Moss	22
12	On the Biosynthetic Origin of Methoxymalonyl-Acyl Carrier Protein, the Substrate for Incorporation of “Glycolate” Units into Ansamitocin and Soraphen A 2006 ·Journal of the American Chemical Society ·Silke C. Wenzel,Rachel Williamson,(unknown),Jun Xu,Klaus Gerth,Rodolfo A. Martinez,Steven J. Moss,Brian J. Carroll,Stephanie Grond,Clifford J. Ünkefer,Rolf Müller,Heinz G. Floss	63
13	Mutasynthesis of Rapamycin Analogues through the Manipulation of a Gene Governing Starter Unit Biosynthesis 2005 ·Angewandte Chemie International Edition ·Matthew A. Gregory,Hrvoje Petković,Rachel E. Lill,Steven J. Moss,Barrie Wilkinson,Sabine Gaisser,Peter F. Leadlay,Rose Sheridan	84
14	Mutasynthesis of Rapamycin Analogues through the Manipulation of a Gene Governing Starter Unit Biosynthesis 2005 ·Angewandte Chemie ·Matthew A. Gregory,Hrvoje Petković,Rachel E. Lill,Steven J. Moss,Barrie Wilkinson,Sabine Gaisser,Peter F. Leadlay,Rose Sheridan	16
15	Loss of co-linearity by modular polyketide synthases: a mechanism for the evolution of chemical diversity 2004 ·Natural Product Reports ·Steven J. Moss,Christine Martin,Barrie Wilkinson	110
16	Biosynthesis of the angiogenesis inhibitor borrelidin by Streptomyces parvulus Tü4055: insights into nitrile formation^† 2004 ·Molecular Microbiology ·Carlos Olano,Steven J. Moss,Alfredo F. Braña,Rose Sheridan,(unknown),Alison J. Weston,Cármen Méndez,Peter F. Leadlay,Barrie Wilkinson,José A. Salas	67
17	Biosynthesis of the Angiogenesis Inhibitor Borrelidin by Streptomyces parvulus Tü4055 2004 ·Chemistry & Biology ·Carlos Olano,Barrie Wilkinson,César Sánchez,Steven J. Moss,Rose Sheridan,(unknown),Alison J. Weston,Alfredo F. Braña,Christine Martin,Markiyan Oliynyk,Cármen Méndez,Peter F. Leadlay,José A. Salas	130
18	Evidence from engineered gene fusions for the repeated use of a module in a modular polyketide synthase 2003 ·Chemical Communications ·Carlos Olano,Barrie Wilkinson,Steven J. Moss,Alfredo F. Braña,Cármen Méndez,Peter F. Leadlay,José A. Salas	56
19	Trial of mammography in women under 50 is ethical 1998 ·BMJ ·Steven J. Moss,Howard Cuckle	0
20	3-アルカノイル-5-ヒドロキシメチルテトロン酸の類縁体 HIV-1プロテアーゼの新阻害剤 2 構造決定 1994 ·The Journal of Antibiotics ·(unknown),(unknown),Steven J. Moss,F. Raschdorf,(unknown)	1

About Steven J. Moss

Steven J. Moss is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (17 papers), Signaling Pathways in Disease (9 papers) and Synthetic Organic Chemistry Methods (8 papers). The work is most often cited by research in Pharmacology (937 citations), Biotechnology (305 citations) and Molecular Biology (1.1k citations). Steven J. Moss has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Barrie Wilkinson, Christine Martin, Peter F. Leadlay, Heinz G. Floss, Rose Sheridan, Tin‐Wein Yu, Linquan Bai, Matthew A. Gregory, Carlos Olano and Cármen Méndez. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact